Marginal Zone Lymphoma - 26 Studies Found Recruiting : Marginal Zone Lymphoma Cohort in Korea : Lymphoma, B-Cell, Marginal Zone : 2016-04-04 : Other: Rituximab Cohort observation study Recruiting : Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) : B-Cell Chronic Lymphocytic Leukemia Monoclonal B-Cell Lymphocytosis Drug: Rituximab 375 mg/m2 IV i Terminated : Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma : Lymphoma : 2012-01-06 : Drug: clarithromycin, oral, high dose 2 g/day clarithromycin (once a day) for 14 days followed by 7 days Completed : Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia : Waldenström Macroglobulinemia Lymphoplasmacytic Lymphoma Drug: Chlorambucil Chlorambuci RECRUITING : FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role : Marginal Zone Lymphoma : 2024-05-11 <<< Previous